Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Respiratory duty cycles in individuals with and without airway hyperresponsiveness.

Blais CM, Davis BE, Graham BL, Cockcroft DW.

Chest. 2019 Sep 19. pii: S0012-3692(19)33870-X. doi: 10.1016/j.chest.2019.09.005. [Epub ahead of print]

PMID:
31542451
2.

Short-term effect of once-daily fluticasone furoate on methacholine-induced bronchoconstriction in mild asthmatics.

Okonkwo CS, Davis BE, Blais CM, Cockcroft DW.

Respir Med. 2019 Sep;156:53-57. doi: 10.1016/j.rmed.2019.08.007. Epub 2019 Aug 13.

PMID:
31434037
3.

Direct bronchoprovocation test methods: history 1945-2018.

Cockcroft DW, Davis BE, Blais CM.

Expert Rev Respir Med. 2019 Mar;13(3):279-289. doi: 10.1080/17476348.2019.1568245. Epub 2019 Jan 24.

PMID:
30632426
4.

ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.

Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, Gauvreau GM, Horvath I, de Jongh FHC, Laube BL, Sterk PJ, Wanger J; American Thoracic Society (ATS)/European Respiratory Society (ERS) Bronchoprovocation Testing Task Force.

Eur Respir J. 2018 Nov 15;52(5). pii: 1801033. doi: 10.1183/13993003.01033-2018. Print 2018 Nov.

PMID:
30361249
5.

Within-tester repeatability and between-tester reproducibility of skin test endpoint titration: A quality assurance study.

Blais CM, Davis BE, Cockcroft DW.

Ann Allergy Asthma Immunol. 2019 Feb;122(2):220-222. doi: 10.1016/j.anai.2018.10.009. Epub 2018 Oct 14. No abstract available.

PMID:
30326324
6.

Bronchoprotective effect of vilanterol against methacholine-induced bronchoconstriction in mild asthmatics: A randomized three-way crossover study.

Westbury GLM, Blais CM, Davis BE, Cockcroft DW.

Ann Allergy Asthma Immunol. 2018 Sep;121(3):328-332. doi: 10.1016/j.anai.2018.07.005. Epub 2018 Jul 12.

PMID:
30017826
7.

Epidemic thunderstorm asthma.

Cockcroft DW.

Lancet Planet Health. 2018 Jun;2(6):e236-e237. doi: 10.1016/S2542-5196(18)30123-2. No abstract available.

8.

Methacholine challenge testing: comparative pharmacology.

Davis BE, Blais CM, Cockcroft DW.

J Asthma Allergy. 2018 May 14;11:89-99. doi: 10.2147/JAA.S160607. eCollection 2018. Review.

9.

Environmental Causes of Asthma.

Cockcroft DW.

Semin Respir Crit Care Med. 2018 Feb;39(1):12-18. doi: 10.1055/s-0037-1606219. Epub 2018 Feb 10. Review.

PMID:
29427981
10.

Thunderstorm asthma: An allergen-induced early asthmatic response.

Cockcroft DW, Davis BE, Blais CM.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):120-123. doi: 10.1016/j.anai.2017.12.002. No abstract available.

PMID:
29413334
11.

Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.

Blais CM, Davis BE, Cockcroft DW.

Respir Med. 2017 Nov;132:109-111. doi: 10.1016/j.rmed.2017.10.002. Epub 2017 Oct 10. No abstract available.

PMID:
29229081
12.

Methacholine Challenge Testing: A Novel Method for Measuring PD20.

Davis BE, Simonson SK, Blais CM, Cockcroft DW.

Chest. 2017 Dec;152(6):1251-1257. doi: 10.1016/j.chest.2017.09.001. Epub 2017 Sep 18.

PMID:
28923758
13.

Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.

Blais CM, Cockcroft DW, Veilleux J, Boulay MÈ, Boulet LP, Gauvreau GM, Scime TX, Watson RM, O'Byrne PM, Davis BE.

J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):88-93. doi: 10.1089/jamp.2017.1392. Epub 2017 Aug 16.

PMID:
28813613
15.
16.

ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.

Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ.

Eur Respir J. 2017 May 1;49(5). pii: 1601526. doi: 10.1183/13993003.01526-2016. Print 2017 May.

17.

The PD20 but not the PC20 in a methacholine challenge test is device independent.

Coates AL, Dell SD, Cockcroft DW, Gauvreau GM.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):508-509. doi: 10.1016/j.anai.2017.01.010. Epub 2017 Mar 6. No abstract available.

PMID:
28274734
18.

Prevalence of allergen sensitization in 1000 adults in Saskatchewan.

Lok SD, Davis BE, Cockcroft DW.

Allergy Asthma Clin Immunol. 2017 Feb 8;13:9. doi: 10.1186/s13223-017-0181-1. eCollection 2017.

19.

Childhood asthma, asthma severity indicators, and related conditions along an urban-rural gradient: a cross-sectional study.

Lawson JA, Rennie DC, Cockcroft DW, Dyck R, Afanasieva A, Oluwole O, Afsana J.

BMC Pulm Med. 2017 Jan 5;17(1):4. doi: 10.1186/s12890-016-0355-5.

20.
21.

Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes.

Cibella F, Campagna D, Caponnetto P, Amaradio MD, Caruso M, Russo C, Cockcroft DW, Polosa R.

Clin Sci (Lond). 2016 Nov 1;130(21):1929-37. doi: 10.1042/CS20160268. Epub 2016 Aug 19.

PMID:
27543458
22.

Airway hyperresponsiveness and chronic obstructive pulmonary disease outcomes.

Cockcroft DW, Wenzel S.

J Allergy Clin Immunol. 2016 Dec;138(6):1580-1581. doi: 10.1016/j.jaci.2016.06.039. Epub 2016 Aug 8. No abstract available.

PMID:
27516214
23.

A dual CysLT1/2 antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma.

Gauvreau GM, Boulet LP, FitzGerald JM, Cockcroft DW, Davis BE, Leigh R, Tanaka M, Fourre JA, Tanaka M, Nabata T, O'Byrne PM.

Allergy. 2016 Dec;71(12):1721-1727. doi: 10.1111/all.12987. Epub 2016 Aug 9.

PMID:
27444660
24.

Allergen inhalation challenge, refractoriness and the effects of ibuprofen.

Nomani S, Cockcroft DW, Davis BE.

Allergy Asthma Clin Immunol. 2016 May 24;12:24. doi: 10.1186/s13223-016-0127-z. eCollection 2016.

25.

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.

Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I, FitzGerald JM, Dahlen B, Killian KJ, Laviolette M, Carlsten C, Lazarinis N, Watson RM, Milot J, Swystun V, Bowen M, Hui L, Lantz AS, Meiser K, Maahs S, Lowe PJ, Skerjanec A, Drollmann A, O'Byrne PM.

J Allergy Clin Immunol. 2016 Oct;138(4):1051-1059. doi: 10.1016/j.jaci.2016.02.027. Epub 2016 Apr 7.

PMID:
27185571
26.

Indoor mold levels and current asthma among school-aged children in Saskatchewan, Canada.

Oluwole O, Kirychuk SP, Lawson JA, Karunanayake C, Cockcroft DW, Willson PJ, Senthilselvan A, Rennie DC.

Indoor Air. 2017 Mar;27(2):311-319. doi: 10.1111/ina.12304. Epub 2016 May 27.

PMID:
27108895
27.

Frederick E. "Freddy" Hargreave, MB ChB, MD.

Cockcroft DW.

Ann Allergy Asthma Immunol. 2016 Apr;116(4):271-3. doi: 10.1016/j.anai.2016.02.007. No abstract available.

PMID:
27055987
28.

Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma.

Boulet LP, Gauvreau GM, Cockcroft DW, Davis B, Vachon L, Cormier Y, O'Byrne PM.

Can Respir J. 2015 Jul-Aug;22(4):230-4.

29.

Respiratory medicine in Saskatchewan: An historical perspective.

Cockcroft DW.

Can Respir J. 2015 Jul-Aug;22(4):197-8. No abstract available.

30.

Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens.

Boulet LP, Gauvreau G, Boulay ME, O'Byrne PM, Cockcroft DW.

Clin Exp Allergy. 2015 Nov;45(11):1647-53. doi: 10.1111/cea.12587.

PMID:
26115509
31.

Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma.

El-Gammal AI, Killian KJ, Scime TX, Beaudin S, Schlatman A, Cockcroft DW, Gauvreau GM.

Ann Am Thorac Soc. 2015 Jul;12(7):1039-43. doi: 10.1513/AnnalsATS.201412-571BC.

PMID:
25871542
32.

Methacholine challenge. PD20 versus PC20.

Cockcroft DW.

Ann Am Thorac Soc. 2015 Mar;12(3):291-2. doi: 10.1513/AnnalsATS.201501-049ED. No abstract available.

PMID:
25786145
33.

Airway responsiveness to mannitol 24 h after allergen challenge in atopic asthmatics.

Davis BE, Amakye DO, Cockcroft DW.

Allergy. 2015 Jun;70(6):682-8. doi: 10.1111/all.12601. Epub 2015 Mar 17.

PMID:
25727851
34.

A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses.

Gauvreau GM, Boulet LP, Leigh R, Cockcroft DW, Killian KJ, Davis BE, Deschesnes F, Watson RM, Swystun V, Mårdh CK, Wessman P, Jorup C, Aurivillius M, O'Byrne PM.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):161-7. doi: 10.1164/rccm.201404-0623OC.

PMID:
25473939
35.

Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases.

Dvorak LA, Vassallo R, Kirmani S, Johnson G, Hartman TE, Tazelaar HD, Leslie KO, Colby TV, Cockcroft DW, Churg AM, Yi ES.

Hum Pathol. 2015 Jan;46(1):147-52. doi: 10.1016/j.humpath.2014.10.003. Epub 2014 Oct 14.

PMID:
25455995
36.

Effect of ingested H₁ antihistamines on methacholine challenge.

Cockcroft DW, Davis BE, Roh Y, Lourens JA.

J Allergy Clin Immunol. 2015 Feb;135(2):579-80. doi: 10.1016/j.jaci.2014.09.013. Epub 2014 Oct 24. No abstract available.

PMID:
25441635
37.

An uncommon cause of wheeze.

Nataraj RT, Cockcroft DW, Fladeland DA.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):616-7. doi: 10.1016/j.jaip.2014.04.005. Epub 2014 May 21. No abstract available.

PMID:
25213058
38.

The necessity of histology.

Nataraj RT, Fladeland DA, Cockcroft DW.

Respir Care. 2015 Jan;60(1):e17-9. doi: 10.4187/respcare.03223. Epub 2014 Aug 26. No abstract available.

39.

Prevalence and determinants of atopy and allergic diseases among school-age children in rural Saskatchewan, Canada.

Chu LM, Rennie DC, Cockcroft DW, Pahwa P, Dosman J, Hagel L, Karunanayake C, Pickett W, Lawson JA.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):430-9. doi: 10.1016/j.anai.2014.07.003. Epub 2014 Aug 14.

PMID:
25129487
40.

Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.

Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y, Dahlén B, Wang Y, Maciuca R, Mayers I, Liao XC, Wu LC, Matthews JG, O'Byrne PM.

Sci Transl Med. 2014 Jul 2;6(243):243ra85. doi: 10.1126/scitranslmed.3008961.

41.

Allergen-induced asthma.

Cockcroft DW.

Can Respir J. 2014 Sep-Oct;21(5):279-82. Epub 2014 May 2. No abstract available.

42.

Low levels of fractional exhaled nitric oxide and deep inhalation bronchoprotection are associated with mannitol non-responsiveness in asthma.

Davis BE, Stewart SL, Martin AL, Cockcroft DW.

Respir Med. 2014 Jun;108(6):859-64. doi: 10.1016/j.rmed.2014.03.005. Epub 2014 Mar 20.

43.

Acute interstitial pulmonary edema.

Tam JS, Fladeland DA, Hergott CA, Cockcroft DW.

Can Respir J. 2014 Mar-Apr;21(2):112-3. Epub 2014 Feb 12. No abstract available.

44.

Are inhaled longacting β2 agonists detrimental to asthma?

Cockcroft DW, Sears MR.

Lancet Respir Med. 2013 Jun;1(4):339-46. doi: 10.1016/S2213-2600(13)70044-4. Epub 2013 May 9. Review.

PMID:
24429159
45.

OX40L blockade and allergen-induced airway responses in subjects with mild asthma.

Gauvreau GM, Boulet LP, Cockcroft DW, FitzGerald JM, Mayers I, Carlsten C, Laviolette M, Killian KJ, Davis BE, Larché M, Kipling C, Dua B, Mosesova S, Putnam W, Zheng Y, Scheerens H, McClintock D, Matthews JG, O'Byrne PM.

Clin Exp Allergy. 2014 Jan;44(1):29-37. doi: 10.1111/cea.12235.

46.

Inhaled allergen bronchoprovocation tests.

Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlén B, O'Byrne PM.

J Allergy Clin Immunol. 2013 Nov;132(5):1045-1055.e6. doi: 10.1016/j.jaci.2013.08.023. Epub 2013 Oct 11. Review.

PMID:
24119772
47.

A posterior pneumothorax.

Tam JS, Hergott CA, Fladeland DA, Cockcroft DW.

Can Respir J. 2013 Sep-Oct;20(5):343-4. No abstract available.

48.

Refractoriness to inhaled mannitol 3 hours after allergen challenge.

Amakye DO, Davis BE, Martin AL, Peters GE, Cockcroft DW.

Ann Allergy Asthma Immunol. 2013 Sep;111(3):182-4. doi: 10.1016/j.anai.2013.06.011. Epub 2013 Jul 12.

PMID:
23987192
49.

Salbutamol tolerance to bronchoprotection: course of onset.

Stewart SL, Martin AL, Davis BE, Cockcroft DW.

Ann Allergy Asthma Immunol. 2012 Dec;109(6):454-7. doi: 10.1016/j.anai.2012.08.003. Epub 2012 Aug 22.

PMID:
23176887
50.

Exercise-induced hyperventilation: more common than appreciated.

Alshati M, Cockcroft DW, Fenton ME.

Ann Allergy Asthma Immunol. 2012 Oct;109(4):282-4. doi: 10.1016/j.anai.2012.07.022. Epub 2012 Aug 21. Review. No abstract available.

PMID:
23010238

Supplemental Content

Loading ...
Support Center